www.fgks.org   »   [go: up one dir, main page]

Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

GISP Profiles, 2010

STD Surveillance, 2010
Participating Sites
Requires Adobe Reader.

Figure A Data - Age of GISP Participants, 2010

Figure B Data - Race/Ethnicity of GISP Participants, 2010

Figure C Data - Percentage of GISP Participants Identifying as Men Who Have Sex with Men, 2000-2010

Figure D Data - Drugs Used to Treat Gonorrhea Among GISP Participants, 2010

Figure E Data - Drugs Used to Treat Chlamydia Trachomatis Infection Among GISP Participants, 2010

Figure F Data - Resistance to Penicillin, Tetracycline, and Ciprofloxacin Among GISP Isolates, 2010

Figure G Data – Distribution of Minimum Inhibitory Concentrations (MICs) to ceftriaxone among GISP isolates, 2005-2010

Figure H Data - Distribution of Minimum Inhibitory Concentrations (MICs) to cefixime among GISP isolates, 2005-2006 and 2010

Figure I Data - Intermediate Resistance and Resistance to Ciprofloxacin Among GISP Isolates, 1990-2010

Figure J Data - Distribution of Minimum Inhibitory Concentrations (MICs) to azithromycin among GISP isolates, 2005-2010

The Gonococcal Isolate Surveillance Project (GISP), a national sentinel surveillance system, was established in 1986 to monitor trends in antimicrobial susceptibilities of Neisseria gonorrhoeae strains in the United States among selected sexually transmitted diseases (STD) clinics in approximately 25-30 GISP sentinel sites.

Annual Reports were published for the years 1998–2007. Starting with 2008 data, site-specific GISP profiles have been published online each year. Aggregated GISP data are presented in the STD Surveillance, 2010 report.

The following site-specific profiles consist of figures depicting the demographic and clinical data of the men with gonorrhea enrolled in GISP and the antimicrobial susceptibility results of the Neisseria gonorrhoeae isolates submitted.


Explanation of Site-Specific Demographic, Clinical, and Laboratory Data

Print all 2010 profiles [PDF - 14 MB]

GISP Profiles (2008-2010) and Annual Reports (1998-2007)

2010 STD Surveillance Report – Gonorrhea

More information about GISP

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #
Web Analytics